Chargement en cours...
Poorly differentiated Sertoli–Leydig tumor with heterologous, high-grade, sarcomatoid features: A case report
• Treatment of sex-cord stromal tumors with carboplatin and taxane is both feasible and safe. • FOXL2 mutations account for approximately 50% of these tumors. • Carboplatin and taxane may afford a favorable outcome.
Enregistré dans:
| Publié dans: | Gynecol Oncol Rep |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Elsevier
2015
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4688826/ https://ncbi.nlm.nih.gov/pubmed/26793762 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.gore.2015.08.001 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|